The role of asymmetric dimethylarginine (ADMA) and leptin in hypertensive patients
| dc.contributor.author | Atamer, A. | |
| dc.contributor.author | Ilan, N. | |
| dc.contributor.author | Kocyigit, Y. | |
| dc.contributor.author | Toprak, G. | |
| dc.contributor.author | Ozbay, M. | |
| dc.contributor.author | Celik, Y. | |
| dc.date.accessioned | 2026-08-12T16:34:59Z | |
| dc.date.issued | 2007 | |
| dc.department | Fırat Üniversitesi | |
| dc.description | 76th Congress of the European-Atherosclerosis-Society -- JUN 10-13, 2007 -- Helsinki, FINLAND | |
| dc.description.abstract | [Abstract Not Available] | |
| dc.description.sponsorship | European Atherosclerosis Soc | |
| dc.identifier.doi | 10.1016/S1567-5688(07)71407-1 | |
| dc.identifier.endpage | 115 | |
| dc.identifier.issn | 1567-5688 | |
| dc.identifier.issue | 1 | |
| dc.identifier.pmid | 18230268 | |
| dc.identifier.scopus | 2-s2.0-39149096877 | |
| dc.identifier.scopusquality | N/A | |
| dc.identifier.startpage | 115 | |
| dc.identifier.uri | https://doi.org/10.1016/S1567-5688(07)71407-1 | |
| dc.identifier.uri | https://hdl.handle.net/11508/44696 | |
| dc.identifier.volume | 8 | |
| dc.identifier.wos | WOS:000247869100459 | |
| dc.identifier.wosquality | N/A | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Ireland Ltd | |
| dc.relation.ispartof | Atherosclerosis Supplements | |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | hypertension | |
| dc.subject | leptin | |
| dc.subject | ADMA | |
| dc.subject | insulin resistance | |
| dc.subject | MDA | |
| dc.subject | lipoproteins | |
| dc.title | The role of asymmetric dimethylarginine (ADMA) and leptin in hypertensive patients | |
| dc.type | Conference Object |







